Biotech IPOs Surge with Strong Performances
Explore the booming biotech IPO market, highlighting successful launches from companies like Maze Therapeutics. Discover key trends and opportunities.
Topic
IPOs
A collection of 13 issues
Nine Companies Aim for $18 Billion in 2025 IPOs
Discover the upcoming IPOs in 2025, where at least nine companies plan to raise a staggering $18 billion, each targeting over $1 billion in funding.
Barclays Forecasts Surge in M&A and IPOs by 2025
Barclays predicts a surge in M&A and IPO activities by 2025, driven by rising stock prices and corporate restructuring. Discover key insights now.
S&P 500 Surge Boosts M&A and IPO Activity
Discover how a 25% increase in the S&P 500 last year is fueling corporate acquisitions and IPOs, offering companies enhanced opportunities for growth.
Barclays' Stephen Dainton Sees 2025 Dealmaking Surge
Stephen Dainton of Barclays predicts a resurgence in dealmaking and IPOs by 2025, fueled by rising US stock prices. Discover the potential market shifts.
Barclays Eyes US Market Growth through Dealmaking and IPOs
Explore how Barclays' strategic focus on the US market could boost revenue through dealmaking and IPO activities. Discover the potential financial impacts.
2025: A Promising Year for IPOs with Lower Interest Rates
2025 is set to be a strong year for IPOs as analysts predict a surge with lower interest rates and a robust lineup of companies ready to go public.
Hong Kong to Host $429 Million in New IPOs
Discover the latest wave of companies planning IPOs in Hong Kong, aiming to raise HK$3.3 billion. Stay updated with Hong Kong's booming stock market.
Companies Rush IPOs Ahead of Trump's Inauguration
Explore why companies are expediting IPOs before Donald Trump's inauguration, amid concerns of potential policy shifts. Stay informed on this evolving financial trend.
Hong Kong IPOs to Raise HK$3.3 Billion
Explore the upcoming wave of Hong Kong IPOs set to raise HK$3.3 billion ($429 million). Stay updated on the latest stock market listings and opportunities.